IMMULITE® 2000 Launched Worldwide

In just three short years, the concept for the IMMULITE 2000, DPC's new, high-throughput immunoassay analyzer, has gone from drawing board to working instrument. The IMMULITE 2000 has now completed a world tour. New features such as primary tube sampling, on-board dilution, reflexive testing, a throughput of up to 200 tests per hour, and ease of use are just a few reasons that clinicians on five continents have welcomed the system.

Development of the IMMULITE 2000, which began in 1993, included consultations with laboratory technologists and other system operators from around the world. Their ideas, coupled with DPC's experience and feedback on the IMMULITE system, were considered in determining what enhancements would allow the IMMULITE 2000 to best fulfill the needs of the busy laboratories of today.

The official worldwide launch of the IMMULITE 2000 began in Chicago, Illinois, at the 1996 AACC, where the new system was introduced to the public for the first time. Groups of laboratory managers, technologists and clinical chemists received demonstrations of the system's features and operation throughout the three exhibit days.

After its introduction in Chicago, the IMMULITE 2000 made its way around the world. Over 20 countries officially launched the IMMULITE 2000 at international clinical chemistry conferences, regional workshops, seminars or gala launch parties.

Technical presenters for the tour included Dr. James Watson, Nobel laureate and DPC board member; Dr. Sigi Ziering, DPC founder, Chairman of the Board and CEO; Dr. Arthur L. Babson, DPC Cirrus Chief Scientist and "father" of IMMULITE and IMMULITE 2000; Dr. Douglas Olson, DPC Cirrus President; and Dotti Bernsten, DPC Director of Systems Support.

From dinner at the Chicago Aquarium with live tropical fish as the exotic backdrop, to amazing circus acts in Belgium, to a dramatic presentation of the IMMULITE 2000 complete with stage smoke and futuristic music at EURO/DPC in Wales, the world tour was an artistic blend of impressive events and technical presentations in beautiful settings. Private and public demonstrations of the system in operation attracted thousands of interested clinicians and technologists.

The IMMULITE 2000 has enjoyed an enthusiastic reception throughout its travels. Laboratorians around the globe have been impressed with the flexibility and ease of use of both the system and the operating software. As the worldwide launch comes to a close with the advent of the system's release to the diagnostic market, we at DPC thank all of our customers and colleagues for taking the time to visit with DPC and the IMMULITE 2000 during its extraordinary international journey.